Goldman Sachs
HURA

Goldman Sachs’s TuHURA Biosciences HURA Stock Holding History

Goldman Sachs’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$308K Buy
131,768
+61,522
+88% +$143K ﹤0.01% 5995
2026
Q1 		$126K Buy
70,246
+31,153
+80% +$38.2K ﹤0.01% 6177
2025
Q4 		$29.6K Buy
+39,093
New +$74.8K ﹤0.01% 6321
2020
Q4 		– Sell
-11
Closed -$28K – 5753
2020
Q3 		$28K Buy
+11
New +$22.1K ﹤0.01% 5233
2017
Q2 		– Sell
-1
Closed -$46K – 7016
2017
Q1 		$46K Hold
1
– – ﹤0.01% 6311
2016
Q4 		$48K Hold
1
– – ﹤0.01% 6396
2016
Q3 		$109K Buy
+1
New +$124K ﹤0.01% 6191

Other funds holding HURA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Goldman Sachs's HURA Position: Q2 2026 in Review

Goldman Sachs increased its TuHURA Biosciences (HURA) stake by 88% in Q2 2026, buying an estimated $143K and bringing the position to 131,768 shares worth $308K. The position accounts for ﹤0.01% of the portfolio, ranked #5995.

Goldman Sachs first reported a position in HURA in Q3 2016 and has held it in 7 quarters since. 89 funds tracked by Wall St. Rank hold HURA as of Q2 2026.

  • Goldman Sachs held 131,768 shares of TuHURA Biosciences worth $308K as of Q2 2026.
  • Goldman Sachs bought 61,522 TuHURA Biosciences shares in Q2 2026, an estimated $143K.
  • TuHURA Biosciences made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #5995 holding.
  • Goldman Sachs first reported a position in TuHURA Biosciences in Q3 2016 and has held it in 7 quarters since.
  • 89 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.